New research continually adds to our knowledge of the effects of…
Category: Oncology
Home /
In mammography, “density” refers to the amount of dense tissue present…
Men with early-stage prostate cancer may have a new tool to…
Scientists have designed a new gene therapy strategy that uses an…
A new contender in the fight against lung cancer has emerged,…
Tecelra®, the first engineered T-cell therapy for solid tumors, has received…
Clinical trial results show that pembrolizumab, an immunotherapy drug used to…
In the early days of the human immunodeficiency virus (HIV) epidemic,…
In a pioneering first-in-human clinical trial, an mRNA cancer vaccine developed…
Around 200,000 people die from glioblastoma, the most common and most…
Recent revelations by celebrities about their cancer diagnoses have cast a…
In 2024, roughly 2 million people in the United States will…
Artificial intelligence (AI) is rapidly transforming the field of oncology, enhancing…
The future of oncology holds immense promise, thanks to the tireless…
Death rates for cancer are lower than ever, having declined as…
The relationship between cancer and the nervous system has been a…
Humans have practiced oncology — the study and treatment of cancer…
Infographics A recent scientific survey conducted by DermTech, Inc. identified a…
Recent years have seen increased research interest in the potential of…
Colonoscopies have historically been the dominant method of screening for early…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
Webinars
The Food Factor: How Diet Shapes Cancer Risk
March 24, 2025
New research continually adds to our knowledge of the effects of diet on cancer risk. Among recent findings, detailed below, are the protective effects of
AI Mammography May Be the Future of Breast Cancer Screening
February 26, 2025
In mammography, “density” refers to the amount of dense tissue present in the breast, as measured on a standard mammogram. Dense tissue, such as glandular
Diet Changes to Slow Prostate Cancer? Omega-3 Study Has Promising Results
February 17, 2025
Men with early-stage prostate cancer may have a new tool to help slow disease progression. A Phase II trial led by researchers at the UCLA
Gene Therapy Targets Mitochondria to Destroy Cancer Cells
February 10, 2025
Scientists have designed a new gene therapy strategy that uses an optogenetic approach to attack cancer cells from the inside. Optogenetics combines genetic engineering and
Bispecific Antibody Drug Shows Cancer Treatment Potential
October 7, 2024
A new contender in the fight against lung cancer has emerged, with strong clinical trial results for ivonescimab, a bispecific antibody from partners Akeso and
Breaking Ground in Cancer Treatment: First T-Cell Therapy Approved for Solid Tumors
September 16, 2024
Tecelra®, the first engineered T-cell therapy for solid tumors, has received approval from the Food and Drug Administration (FDA) for advanced MAGE-A4+ synovial sarcoma in
Game-Changing Drug for Colon Cancer May Redefine Treatment
August 19, 2024
Clinical trial results show that pembrolizumab, an immunotherapy drug used to treat multiple types of cancer, can dramatically improve outcomes for patients with colorectal cancer
Mapping the Evolution of HIV Treatment and the Path to a Cure
July 24, 2024
In the early days of the human immunodeficiency virus (HIV) epidemic, there was little hope. HIV infection, when untreated, damages the immune system, making people
mRNA Cancer Vaccine Shows Promise Against Glioblastoma
July 8, 2024
In a pioneering first-in-human clinical trial, an mRNA cancer vaccine developed at the University of Florida (UF) has shown promise in treating patients with primary
CAR-T Cell Therapy Shows Promise in Treating Aggressive Brain Tumors
June 13, 2024
Around 200,000 people die from glioblastoma, the most common and most aggressive type of cancerous brain tumor, each year. With a five-year overall survival rate
Understanding the Rise in Cancer Rates Among Young Adults
May 13, 2024
Recent revelations by celebrities about their cancer diagnoses have cast a spotlight on a worrisome trend: the rise in early-onset cancer rates, or the incidence
Oncology Clinical Trials: Understanding Industry Challenges
May 8, 2024
In 2024, roughly 2 million people in the United States will be diagnosed with cancer, per the National Cancer Institute. Given that stark statistic, oncology
Boosting Oncology Research with Artificial Intelligence
May 6, 2024
Artificial intelligence (AI) is rapidly transforming the field of oncology, enhancing the precision of cancer diagnostics and accelerating drug development processes. AI and machine learning
The Future of Oncology Treatment
May 1, 2024
The future of oncology holds immense promise, thanks to the tireless efforts of medical researchers. From innovative oncology drugs like antibody-drug conjugates to advancements in
Oncology Drug Development: The Current State of Affairs
April 29, 2024
Death rates for cancer are lower than ever, having declined as much as 33 percent since 1991. This is largely thanks to innovations in oncology
Hacking the Nervous System to Improve Cancer Treatment
April 22, 2024
The relationship between cancer and the nervous system has been a curiosity and mystery for nearly two centuries. Jean Cruveilhier’s initial observations in the early
Oncology Drug Development: A Short History
April 17, 2024
Humans have practiced oncology — the study and treatment of cancer — since long before the invention of the scalpel. The history of oncology drug
Skin Cancer Risk Concerningly High in Millennials & Gen Xers
May 24, 2023
Infographics A recent scientific survey conducted by DermTech, Inc. identified a number of alarming trends concerning the sun exposure habits and skin health knowledge of
Precision Steering of CAR-T Therapies May Effectively Target More Tumor Types
March 13, 2023
Recent years have seen increased research interest in the potential of chimeric antigen receptor (CAR)-T cancer therapies. This approach uses genetic engineering to modify T
Is Stool Screening an Effective Tool for Preventing Colon Cancer?
February 15, 2023
Colonoscopies have historically been the dominant method of screening for early detection of colon cancer, the third leading cause of cancer death in the United
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
